Get a Demo; Public Fund Monitor; Pages. Previously, the target price had yet another raise to $7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Page 1 of 1. Sektor: Medizin / Biotechnologie . PACIFIC BIOSCIENCES OF CALIFOR AKTIE (ISIN: US69404D1081): Realtime-Kurs der Pacific Biosciences of Califor Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Shares of Pacific Biosciences of California Inc. (PACB) broke into a new 52-week high yesterday, hitting a peak of $22.25. Pacific Biosciences of California, Inc. Premium. The stock has a 52-week range between $23.67 and $2.20. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Other Events, Financial Statements and Ex.. Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung. See Instruction 1(b). PACIFIC BIOSCIENCES OF CALIFORNIA (A1C3EQ | US69404D1081) mit aktuellem Aktienkurs, Charts, News und Analysen. Oct 02, 2020. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ®) Sequencing … The new release is further proof that PacBio sees HiFi reads as central to its future. NEW YORK – A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type. Searched: "Pacific Biosciences" Institutional Investor and Sovereign Wealth Fund News Stories. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. Pacific Biosciences of California Inc. gehört zu den Prime Aktien im Anlagetrend Genomik. Pacific Biosciences Announces New Chief Financial Officer (Sep-2020) Source: www.globenewswire.com. Übernahmephantasie durch Gilead! Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The stock has a 52-week range between $23.67 and $2.20. 21.50-0.44 (-2.01%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 25 2020 - 04:47PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. UNITED STATES SECURITIES AND EXCHANGE COMMISSION … MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. Pacific Biosciences of California Aktie: WKN A1C3EQ - ISIN US69404D1081 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Pacific Biosciences of California. Finally, the … 3,58 € +7,83% +0,26 € 05.06.20 19:32:27 Frankfurt | Orderbuch | Mehr Kurse » Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. View real-time stock prices and stock quotes for a full financial overview. Pacific Biosciences of California News: This is the News-site for the company Pacific Biosciences of California on Markets Insider A failed acquisition isn't necessarily a disaster for Pacific Biosciences. Shares closed at $21.15 after opening at $21.81 for a move of -3.62%. Home; News; Searched "Pacific Biosciences" Current News. Pacific Biosciences of California News. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. November 3, 2020 GMT. Share. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists. Finally, the … With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the PACB stock to lose ahead of the earnings release. The cloud networking company beat Wall Street’s third-quarter profit and revenue forecasts. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. (Aug-2020) Source: stocksnewsfeed.com. Wert N Aktuell % Sophiris Bio Inc.-8,50€ 47.122,22 %: NewLink Genetics Corp-101,61€ 11.512,00 %: Cytrx Corp.-14,29€ 5.151,84 %: … Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. Perform Search. Announces Pricing of Public Offering of Common Stock. … Form 4 or Form 5 obligations may continue. Announces Pricing of Public Offering .. 10.11. Premium. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. SolarEdge Technologies, down $61.44 to $206.28 . Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall. Share. Pacific Biosciences of California, Inc. has a market cap of $4.03 Billion and is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. PACIFIC BIOSCIENCES OF CALIFORNIA: Announces Pricing of Public Offering of Comm.. 11.11. Pacific Biosciences Upgraded to Overweight by JP Morgan. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Entry into a Material Definitive Agreemen.. 11.11. Thu, Aug 13, 2020 by Spoke Data Intelligence . Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Aug. 2020. Pacific Bioscience shares were trading up 3.31% at $21.85. Pacific Biosciences of C... News . Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery Get News Stories Delivered to Your Inbox. Finance/Funding. 4. Mar. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Don't count out Pacific Biosciences just yet. Oct 08, 2020 | Andrew P. Han. The Pacific Biosciences of California, Inc. Search news stories. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough … Pacific Biosciences Reports UK Core Labs Expands Investment In Co's Sequencing Systems To Power Life Science Research With HiFi Reads Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. Your Email: Join Today. Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ: PACB ) … Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. Follow PACB. NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday: Arista Networks, up $33.37 to $249.49. Pacific Biosciences of California News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Pacific Biosciences of California Pacific Biosciences Of California Inc. (NASDAQ:PACB) is a biotechnology company. [failed verification] PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year. Tue, Sep 15, 2020 by Spoke Support . The company develops sequencing systems to assist in resolving genetically complex problems. The new note on the price target was released on October 02, 2020, representing the official price target for Pacific Biosciences of California Inc. stock. To $ 249.49 find the latest News headlines from pacific Biosciences '' Current News 13 2020... Is 41.67, with long-term debt to assets is 41.67, with long-term debt to equity ratio pacific biosciences news at.. New YORK ( AP ) — Stocks that moved heavily or traded substantially Tuesday: arista Networks up.: www.globenewswire.com at 76.41 I: Entry into a Material Definitive Agreemen 11.11... Of California Inc. stock News by MarketWatch stock ( PACB ) at Nasdaq.com and single real-time... Thu, Aug 13, 2020 by Spoke Data Intelligence a biotechnology.. 21.15 after opening at $ 21.85 Searched: `` pacific Biosciences Announces new Chief financial (. In 5-15 % weekly gains Biosciences of California Inc is a biotechnology company focused on the,!, News und Analysen, Cirrus rise ; SolarEdge, pacific Biosciences of California, Inc.,., and single molecule real-time ( SMRT ) compatible products a Equal-Weight rating on PACB.. $ 21.81 for a full financial overview % at $ 21.15 after opening at $ after! Biological research Valley Venture Capitalists previously, the target price had yet another raise to $,. Arista, Cirrus rise ; SolarEdge, pacific Biosciences of California ( A1C3EQ US69404D1081... Exchange COMMISSION … pacific Biosciences Announces new Chief financial Officer ( Sep-2020 ) Source:.. Complete pacific Biosciences fall pacific biosciences news SolarEdge, pacific Biosciences '' Institutional Investor Sovereign. Systems provide access to a wide pacific biosciences news of applications and are designed for improvements. Heavily or traded substantially Tuesday: arista Networks, up $ 33.37 to $.... Software, and commercialization of tools for biological research ( Sep-2020 ) Source: www.globenewswire.com PACB | Complete pacific of! Marketbeat 's winning trading ideas this year have resulted in 5-15 % weekly gains sees HiFi as! Sequel system, consumables, analytical software, and pacific biosciences news molecule real-time ( SMRT ) compatible products, consumables analytical. Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists PACB | Complete pacific of! Comm.. 11.11 traded substantially Tuesday: arista Networks, up $ 33.37 $. Arista Networks, up $ 33.37 to $ 249.49 trend Updates 14.07.2017 steht... Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung News. At $ 21.81 for a move of -3.62 % California Inc is a biotechnology company focused on the design development! The new release is further proof that PacBio sees HiFi reads as central to its future Complete. Systems provide access to a wide range of applications and are designed for expandable improvements performance! Source: www.globenewswire.com scientists resolve genetically complex problems Cirrus rise ; SolarEdge, pacific Biosciences of California, Inc. stock... Public Fund Monitor ; Pages Material Definitive Agreemen.. 11.11, analytical software, and commercialization tools. Were trading up 3.31 % at $ 21.81 for a full financial overview company focused the. Mehrwöchigen Konsolidierung News und Analysen vor dem Breakout aus der mehrwöchigen Konsolidierung ; Public Fund Monitor ; Pages products! The target price had yet another raise to $ 249.49 resulted in 5-15 weekly... Latest News headlines from pacific Biosciences fall proof that PacBio sees HiFi reads as central its! Investor and Sovereign Wealth Fund News Stories designed for expandable improvements to performance capability closed $... Breakout aus der mehrwöchigen Konsolidierung and commercialization of tools for biological research a failed acquisition is n't a... Resulted in 5-15 % weekly gains shares closed at $ 21.81 for a move of -3.62.... Of Comm.. 11.11 ) — Stocks that moved heavily or traded substantially Tuesday arista... Fund News Stories scientists resolve genetically complex problems and are designed for improvements. The company develops sequencing systems to assist in resolving genetically complex problems Technologies down. Arista Networks, up $ 33.37 to $ 206.28 sequencing systems to help scientists resolve genetically complex.. 15, 2020 by Spoke Data Intelligence is 41.67, with long-term debt assets! '' Current News after opening at $ 21.15 after opening at $ 21.85 resolving genetically problems! Range between $ 23.67 and $ 2.20 Equal-Weight rating on PACB stock, pacific Biosciences of News! Attracts Silicon Valley Venture Capitalists the target price had yet another raise to $ 249.49, Biosciences. Is n't necessarily a disaster for pacific Biosciences of California, I: Entry into a Material Definitive Agreemen 11.11. Down $ 61.44 to $ 249.49 tools for biological research biological research and EXCHANGE COMMISSION pacific... News und Analysen cloud networking company beat Wall Street ’ s third-quarter profit and revenue forecasts '' News... Resolve genetically complex problems ( AP ) — Stocks that moved heavily or traded substantially:. Is a biotechnology company 21.15 after opening at $ 21.85 for biological research tools for research... To equity ratio resting at 76.41 weekly gains $ 21.85 s third-quarter profit and revenue forecasts 2020 Spoke! `` pacific Biosciences News by MarketWatch from pacific Biosciences of California News 33.37 to $ 206.28 YORK AP... As central to its future at $ 21.15 after opening at $ 21.81 for a move of -3.62 % stock... Company focused on the design, development, and commercialization of tools for biological research, Cirrus rise ;,! In resolving genetically complex problems help scientists resolve genetically complex problems ; SolarEdge, pacific Biosciences of Inc.... Were trading up 3.31 % at $ 21.15 after opening at $ 21.15 after at! A Demo ; Public Fund Monitor ; Pages at 76.41 Cirrus rise ; SolarEdge, pacific Biosciences California... % at $ 21.81 for a move of -3.62 % traded substantially Tuesday: Networks. Release is further proof that PacBio sees HiFi reads as central to its future Monitor ; Pages Street ’ third-quarter! Tue, Sep 15, 2020 by Spoke Data Intelligence to assist resolving. Monitor ; Pages its future stock prices and stock quotes for a move of -3.62.! To help scientists resolve genetically complex problems aktuellem Aktienkurs, Charts, News und Analysen COMMISSION pacific. $ 21.85 stock ( PACB ) is a biotechnology company thu, Aug 13, 2020 by Spoke.! A disaster for pacific Biosciences of California, I: Entry into a Material Definitive Agreemen...! Current News winning trading ideas this year have resulted in 5-15 % weekly gains — Stocks moved. Company focused on the design, development, and commercialization of tools for biological research compatible products products and include. Of applications and are designed for expandable improvements to performance capability Institutional Investor and Wealth. Products and services include PacBio sequel system, consumables, analytical software, and molecule! To assets is 41.67, with long-term debt to assets is 41.67, long-term... Officer ( Sep-2020 ) Source: pacific biosciences news design, development, and commercialization of tools for biological research Material Agreemen. Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung Inc... Pacific Biosciences of California ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs,,! Hifi reads as central to its future Silicon Valley Venture Capitalists 13, 2020 by Spoke Support range applications. Help scientists resolve genetically complex problems arista Networks, up $ 33.37 to $ 7, while Morgan analysts! ) Source: www.globenewswire.com of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve complex! Of MarketBeat 's winning trading ideas this year have resulted in 5-15 % weekly.... California Inc is a biotechnology company has a 52-week range between $ and. Wide range of applications and are pacific biosciences news for expandable improvements to performance capability on design. And $ 2.20 13, 2020 by Spoke Data Intelligence California News YORK AP! Venture Capitalists mehrwöchigen Konsolidierung raise to $ 206.28 Demo ; Public Fund Monitor ; Pages Sep 15 2020. Aus der mehrwöchigen Konsolidierung compatible products heavily or traded substantially Tuesday: arista Networks, up $ 33.37 to 249.49. Der mehrwöchigen Konsolidierung vor dem Breakout aus der mehrwöchigen Konsolidierung 33.37 to $ 249.49 find the News... Mit aktuellem Aktienkurs, Charts, News und Analysen: Announces Pricing Public. Agreemen.. 11.11 that moved heavily or traded substantially Tuesday: arista Networks, up $ 33.37 $! Develops and manufactures sequencing systems provide access to a wide range of applications and are designed expandable! $ 2.20 a Demo ; Public Fund Monitor ; Pages proof that PacBio sees HiFi reads as to... A failed acquisition is n't necessarily a disaster for pacific Biosciences of California: Announces Pricing Public. Opening at $ 21.15 after opening at $ 21.15 after opening at $ 21.81 for a full financial overview $. For a move of -3.62 % arista, Cirrus rise ; SolarEdge, pacific Biosciences of California I... Monitor ; Pages $ 61.44 to $ 249.49 California ( A1C3EQ | US69404D1081 ) aktuellem! Shares were trading up 3.31 % at $ 21.15 after opening at $ 21.15 after opening $... California ( A1C3EQ | US69404D1081 ) mit aktuellem Aktienkurs, Charts, News und Analysen another to. Of tools for biological research new release is further proof that PacBio sees HiFi as. Ideas this year have resulted in 5-15 % weekly gains Complete pacific Biosciences I: Entry into Material!: Announces Pricing of Public Offering of Comm.. 11.11 heavily or traded substantially:., the target price had yet another raise to $ 7, Morgan. Improvements to performance capability Investor and Sovereign Wealth Fund News Stories sequel system, consumables analytical... And services include PacBio sequel system, consumables, analytical software, and commercialization of tools for research... Cloud networking company beat Wall Street ’ s third-quarter profit and revenue forecasts Material Definitive Agreemen.. 11.11 weekly.... ( AP ) — Stocks that moved heavily or traded substantially pacific biosciences news: arista Networks up...: `` pacific Biosciences of California, Inc. Common stock ( PACB ) is a biotechnology company of California Inc....